Vault-13

Ikarian Capital, LLC

DALLAS, TX · CIK 1778253 · 13F filing filed 2022-05-13

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$328.7m reported value -5.9% vs Q4 2021
155positions
37.8%in top 10
16 new 124 added 11 reduced 10 sold out vs Q4 2021

Options: 29 call positions ($347.7m notional), 12 put positions ($84.0m notional) – listed below, not included above.

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BICYCLE THERAPEUTICS PLC SPONSORED ADS BCYC BCYC 478,784 $21.0m6.39% 6.39% ReducedShares held: Q2 2021 0, Q3 2021 526.5k, Q4 2021 613.1k, Q1 2022 478.8k -134.3k -134,342 -21.9%
2 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 537,958 $18.3m5.57% 5.57% AddedShares held: Q2 2021 365.5k, Q3 2021 270.4k, Q4 2021 419.2k, Q1 2022 538.0k +118.7k +118,742 28.3%
3 KEZAR LIFE SCIENCES INC COM COM 1,083,116 $18.0m5.48% 5.48% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 1.0m, Q1 2022 1.1m +62.2k +62,199 6.1%
4 MILESTONE PHARMACEUTICALS IN COM MIST MIST 1,928,752 $12.4m3.77% 3.77% AddedShares held: Q2 2021 2.0m, Q3 2021 1.8m, Q4 2021 1.8m, Q1 2022 1.9m +178.7k +178,709 10.2%
5 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 110,116 $11.6m3.52% 3.52% AddedShares held: Q2 2021 54.8k, Q3 2021 25.7k, Q4 2021 75.7k, Q1 2022 110.1k +34.5k +34,455 45.5%
6 ADICET BIO INC COM COM 507,348 $10.1m3.08% 3.08% AddedShares held: Q2 2021 125.5k, Q3 2021 392.4k, Q4 2021 477.4k, Q1 2022 507.3k +29.9k +29,930 6.3%
7 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 202,203 $9.3m2.84% 2.84% AddedShares held: Q2 2021 0, Q3 2021 92.3k, Q4 2021 191.1k, Q1 2022 202.2k +11.1k +11,063 5.8%
8 SAGE THERAPEUTICS INC COM SAGE SAGE 249,907 $8.3m2.52% 2.52% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 249.9k
9 VAXCYTE INC COM PCVX PCVX 315,991 $7.6m2.32% 2.32% AddedShares held: Q2 2021 448.1k, Q3 2021 295.1k, Q4 2021 295.1k, Q1 2022 316.0k +20.9k +20,880 7.1%
10 TRACON PHARMACEUTICALS INC COM NEW COM NEW 2,843,232 $7.5m2.27% 2.27% AddedShares held: Q2 2021 2.7m, Q3 2021 2.7m, Q4 2021 2.7m, Q1 2022 2.8m +152.1k +152,122 5.7%
11 XENON PHARMACEUTICALS INC COM XENE XENE 239,441 $7.3m2.23% 2.23% AddedShares held: Q2 2021 640.6k, Q3 2021 377.4k, Q4 2021 179.1k, Q1 2022 239.4k +60.3k +60,303 33.7%
12 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 60,000 $7.1m2.16% 2.16% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 60.0k
13 SIERRA ONCOLOGY INC COM NEW COM NEW 217,915 $7.0m2.12% 2.12% ReducedShares held: Q2 2021 545.0k, Q3 2021 573.4k, Q4 2021 569.0k, Q1 2022 217.9k -351.1k -351,114 -61.7%
14 GOSSAMER BIO INC COM GOSS GOSS 775,315 $6.7m2.05% 2.05% ReducedShares held: Q2 2021 1.0m, Q3 2021 1.4m, Q4 2021 1.2m, Q1 2022 775.3k -391.6k -391,618 -33.6%
15 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 25,000 $6.5m1.98% 1.98% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 25.0k
16 RIGEL PHARMACEUTICALS INC COM NEW COM NEW 2,137,128 $6.4m1.94% 1.94% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 439.4k, Q1 2022 2.1m +1.7m +1,697,772 386.4%
17 KARUNA THERAPEUTICS INC COM COM 50,000 $6.3m1.93% 1.93% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 50.0k
18 BELLUS HEALTH INC NEW COM NEW BLU BLU 913,327 $6.3m1.91% 1.91% AddedShares held: Q2 2021 1.0m, Q3 2021 744.6k, Q4 2021 50.0k, Q1 2022 913.3k +863.3k +863,327 1726.7%
19 IMMATICS N.V SHS IMTX IMTX 781,388 $6.2m1.90% 1.90% AddedShares held: Q2 2021 225.1k, Q3 2021 883.0k, Q4 2021 737.5k, Q1 2022 781.4k +43.8k +43,842 5.9%
20 SERES THERAPEUTICS INC COM COM 840,624 $6.0m1.82% 1.82% AddedShares held: Q2 2021 0, Q3 2021 606.6k, Q4 2021 795.9k, Q1 2022 840.6k +44.7k +44,721 5.6%
21 SCPHARMACEUTICALS INC COM SCPH SCPH 970,098 $5.5m1.68% 1.68% AddedShares held: Q2 2021 1.1m, Q3 2021 901.4k, Q4 2021 901.4k, Q1 2022 970.1k +68.7k +68,736 7.6%
22 GALAPAGOS NV SPON ADR LKFT LKFT 86,865 $5.4m1.65% 1.65% UnchangedShares held: Q2 2021 200.0k, Q3 2021 86.9k, Q4 2021 86.9k, Q1 2022 86.9k
23 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 396,654 $5.1m1.55% 1.55% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 396.7k
24 AMGEN INC COM AMGN AMGN 20,000 $4.8m1.47% 1.47% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 20.0k
25 PFIZER INC COM PFE PFE 80,000 $4.1m1.26% 1.26% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 80.0k
26 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 50,000 $3.9m1.17% 1.17% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 50.0k
27 CHIMERIX INC COM CMRX CMRX 841,203 $3.9m1.17% 1.17% AddedShares held: Q2 2021 1.6m, Q3 2021 801.3k, Q4 2021 795.4k, Q1 2022 841.2k +45.8k +45,793 5.8%
28 AADI BIOSCIENCE INC COM WHWK WHWK 208,368 $3.5m1.08% 1.08% AddedShares held: Q2 2021 0, Q3 2021 11.4k, Q4 2021 196.4k, Q1 2022 208.4k +12.0k +11,960 6.1%
29 INHIBRX INC COM INBX INBX 157,842 $3.5m1.07% 1.07% AddedShares held: Q2 2021 8.1k, Q3 2021 289.9k, Q4 2021 149.8k, Q1 2022 157.8k +8.0k +7,992 5.3%
30 INTELLIA THERAPEUTICS INC COM NTLA NTLA 47,408 $3.4m1.05% 1.05% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 47.4k
31 REATA PHARMACEUTICALS INC CL A RETA RETA 86,905 $2.8m0.87% 0.87% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 86.9k
32 AYALA PHARMACEUTICALS INC COM COM 708,383 $2.8m0.86% 0.86% AddedShares held: Q2 2021 0, Q3 2021 538.9k, Q4 2021 669.3k, Q1 2022 708.4k +39.1k +39,112 5.8%
33 SATSUMA PHARMACEUTICALS INC COM STSA STSA 653,448 $2.5m0.76% 0.76% AddedShares held: Q2 2021 644.1k, Q3 2021 629.4k, Q4 2021 629.4k, Q1 2022 653.4k +24.1k +24,064 3.8%
34 X4 PHARMACEUTICALS INC COM COM 1,372,022 $2.4m0.73% 0.73% ReducedShares held: Q2 2021 2.7m, Q3 2021 2.5m, Q4 2021 2.3m, Q1 2022 1.4m -892.5k -892,469 -39.4%
35 PARDES BIOSCIENCES INC COM COM 323,934 $2.3m0.71% 0.71% ReducedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 400.0k, Q1 2022 323.9k -76.1k -76,066 -19.0%
36 OVID THERAPEUTICS INC COM OVID OVID 738,372 $2.3m0.71% 0.71% AddedShares held: Q2 2021 1.1m, Q3 2021 1.1m, Q4 2021 705.1k, Q1 2022 738.4k +33.3k +33,290 4.7%
37 SAVARA INC COM SVRA SVRA 1,622,552 $2.1m0.65% 0.65% AddedShares held: Q2 2021 1.6m, Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.6m +82.9k +82,861 5.4%
38 KYMERA THERAPEUTICS INC COM KYMR KYMR 50,000 $2.1m0.64% 0.64% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 50.0k
39 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 1,048,039 $2.1m0.64% 0.64% AddedShares held: Q2 2021 0, Q3 2021 993.5k, Q4 2021 993.5k, Q1 2022 1.0m +54.6k +54,558 5.5%
40 CABALETTA BIO INC COM CABA CABA 1,020,070 $2.1m0.63% 0.63% AddedShares held: Q2 2021 947.1k, Q3 2021 1.2m, Q4 2021 970.4k, Q1 2022 1.0m +49.7k +49,672 5.1%
41 CONNECT BIOPHARMA HLDGS LTD ADS ADS 677,859 $2.0m0.62% 0.62% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 262.2k, Q1 2022 677.9k +415.6k +415,622 158.5%
42 CLENE INC COMMON STOCK CLNN CLNN 514,283 $2.0m0.62% 0.62% AddedShares held: Q2 2021 118.5k, Q3 2021 489.3k, Q4 2021 489.3k, Q1 2022 514.3k +25.0k +24,962 5.1%
43 LIQUIDIA CORPORATION COM NEW LQDA LQDA 243,904 $1.8m0.53% 0.53% ReducedShares held: Q2 2021 890.4k, Q3 2021 884.9k, Q4 2021 325.4k, Q1 2022 243.9k -81.5k -81,541 -25.1%
44 GLOBAL BLOOD THERAPEUTICS IN COM GBT GBT 49,997 $1.7m0.53% 0.53% ReducedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 164.1k, Q1 2022 50.0k -114.1k -114,085 -69.5%
45 LYRA THERAPEUTICS INC COM LYRA LYRA 422,338 $1.7m0.52% 0.52% AddedShares held: Q2 2021 624.7k, Q3 2021 403.4k, Q4 2021 394.5k, Q1 2022 422.3k +27.8k +27,802 7.0%
46 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 375,000 $1.7m0.51% 0.51% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 375.0k
47 FINCH THERAPEUTICS GROUP INC COM COM 330,523 $1.7m0.51% 0.51% AddedShares held: Q2 2021 325.0k, Q3 2021 315.7k, Q4 2021 315.7k, Q1 2022 330.5k +14.8k +14,791 4.7%
48 VIKING THERAPEUTICS INC COM VKTX VKTX 532,429 $1.6m0.49% 0.49% AddedShares held: Q2 2021 524.8k, Q3 2021 500.6k, Q4 2021 500.6k, Q1 2022 532.4k +31.8k +31,787 6.3%
49 CLOVIS ONCOLOGY INC COM CLVS CLVS 772,339 $1.6m0.47% 0.47% ReducedShares held: Q2 2021 1.1m, Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 772.3k -340.3k -340,330 -30.6%
50 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 372,217 $1.6m0.47% 0.47% ReducedShares held: Q2 2021 1.4m, Q3 2021 544.8k, Q4 2021 544.8k, Q1 2022 372.2k -172.6k -172,602 -31.7%
51 PROTARA THERAPEUTICS INC COM STK TARA TARA 296,426 $1.5m0.46% 0.46% AddedShares held: Q2 2021 584.8k, Q3 2021 480.0k, Q4 2021 279.3k, Q1 2022 296.4k +17.2k +17,170 6.2%
52 AILERON THERAPEUTICS INC COM ALRN ALRN 2,902,086 $1.5m0.45% 0.45% AddedShares held: Q2 2021 2.8m, Q3 2021 2.8m, Q4 2021 2.8m, Q1 2022 2.9m +138.5k +138,503 5.0%
53 RENOVACOR INC COM COM 343,283 $1.5m0.44% 0.44% AddedShares held: Q2 2021 0, Q3 2021 442.9k, Q4 2021 342.9k, Q1 2022 343.3k +381 +381 0.1%
54 MACROGENICS INC COM MGNX MGNX 164,119 $1.4m0.44% 0.44% AddedShares held: Q2 2021 459.6k, Q3 2021 188.5k, Q4 2021 156.0k, Q1 2022 164.1k +8.1k +8,072 5.2%
55 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 362,537 $1.4m0.43% 0.43% AddedShares held: Q2 2021 350.0k, Q3 2021 344.6k, Q4 2021 344.6k, Q1 2022 362.5k +18.0k +17,959 5.2%
56 MERUS N V COM MRUS MRUS 53,703 $1.4m0.43% 0.43% AddedShares held: Q2 2021 51.2k, Q3 2021 50.9k, Q4 2021 50.9k, Q1 2022 53.7k +2.8k +2,796 5.5%
57 VASCULAR BIOGENICS LTD COM COM 830,747 $1.4m0.43% 0.43% AddedShares held: Q2 2021 800.8k, Q3 2021 790.8k, Q4 2021 790.8k, Q1 2022 830.7k +39.9k +39,909 5.0%
58 CHEMOMAB THERAPEUTICS LTD SPONSORED ADS SPONSORED ADS 268,104 $1.3m0.39% 0.39% AddedShares held: Q2 2021 290.5k, Q3 2021 285.3k, Q4 2021 265.3k, Q1 2022 268.1k +2.8k +2,840 1.1%
59 SYNLOGIC INC COM COM 519,775 $1.2m0.38% 0.38% AddedShares held: Q2 2021 848.4k, Q3 2021 788.8k, Q4 2021 483.8k, Q1 2022 519.8k +36.0k +35,957 7.4%
60 ANEBULO PHARMACEUTICALS INC COM ANEB ANEB 181,199 $1.2m0.37% 0.37% AddedShares held: Q2 2021 174.8k, Q3 2021 172.3k, Q4 2021 172.3k, Q1 2022 181.2k +8.9k +8,890 5.2%
61 SYNAPTOGENIX INC COM NEW COM NEW 153,226 $1.2m0.36% 0.36% AddedShares held: Q2 2021 300.0k, Q3 2021 245.6k, Q4 2021 145.6k, Q1 2022 153.2k +7.6k +7,597 5.2%
62 BELLICUM PHARMACEUTICALS INC COM NEW BLCM BLCM 523,348 $1.1m0.34% 0.34% AddedShares held: Q2 2021 500.0k, Q3 2021 496.8k, Q4 2021 496.8k, Q1 2022 523.3k +26.6k +26,592 5.3%
63 NUVATION BIO INC COM CL A NUVB NUVB 213,310 $1.1m0.34% 0.34% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 200.0k, Q1 2022 213.3k +13.3k +13,310 6.7%
64 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 87,071 $1.1m0.33% 0.33% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 82.3k, Q1 2022 87.1k +4.7k +4,736 5.8%
65 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 78,550 $1.1m0.33% 0.33% AddedShares held: Q2 2021 100.0k, Q3 2021 99.6k, Q4 2021 74.6k, Q1 2022 78.5k +4.0k +3,990 5.3%
66 CASI PHARMACEUTICALS INC COM CASI CASI 1,320,155 $1.1m0.32% 0.32% AddedShares held: Q2 2021 1.3m, Q3 2021 1.2m, Q4 2021 1.2m, Q1 2022 1.3m +97.1k +97,088 7.9%
67 DBV TECHNOLOGIES S A SPONSORED ADR SPONSORED ADR 316,939 $1.0m0.32% 0.32% AddedShares held: Q2 2021 322.7k, Q3 2021 310.1k, Q4 2021 310.1k, Q1 2022 316.9k +6.8k +6,829 2.2%
68 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 8,763 $1.0m0.31% 0.31% AddedShares held: Q2 2021 21.8k, Q3 2021 0, Q4 2021 8.4k, Q1 2022 8.8k +363 +363 4.3%
69 BRAINSTORM CELL THERAPEUTICS COM NEW COM NEW 304,161 $1.0m0.31% 0.31% AddedShares held: Q2 2021 293.2k, Q3 2021 289.6k, Q4 2021 289.6k, Q1 2022 304.2k +14.6k +14,611 5.0%
70 MAXCYTE INC COM MXCT MXCT 137,958 $964.0k0.29% 0.29% AddedShares held: Q2 2021 0, Q3 2021 150.0k, Q4 2021 130.0k, Q1 2022 138.0k +8.0k +7,958 6.1%
71 VERASTEM INC COM COM 678,023 $956.0k0.29% 0.29% AddedShares held: Q2 2021 1.4m, Q3 2021 1.2m, Q4 2021 637.4k, Q1 2022 678.0k +40.7k +40,652 6.4%
72 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 510,126 $837.0k0.25% 0.25% AddedShares held: Q2 2021 100.0k, Q3 2021 757.5k, Q4 2021 482.6k, Q1 2022 510.1k +27.5k +27,516 5.7%
73 IVERIC BIO INC COM OPHT OPHT 49,099 $825.0k0.25% 0.25% AddedShares held: Q2 2021 0, Q3 2021 216.5k, Q4 2021 46.5k, Q1 2022 49.1k +2.6k +2,580 5.5%
74 BCLS ACQUISITION CORP COM CL A COM CL A 77,274 $762.0k0.23% 0.23% AddedShares held: Q2 2021 75.1k, Q3 2021 73.8k, Q4 2021 73.8k, Q1 2022 77.3k +3.5k +3,485 4.7%
75 HEPION PHARMACEUTICALS INC COM COM 582,137 $751.0k0.23% 0.23% AddedShares held: Q2 2021 1.4m, Q3 2021 553.3k, Q4 2021 553.3k, Q1 2022 582.1k +28.9k +28,864 5.2%
76 PANBELA THERAPEUTICS INC COM COM 355,959 $750.0k0.23% 0.23% AddedShares held: Q2 2021 345.0k, Q3 2021 338.4k, Q4 2021 338.4k, Q1 2022 356.0k +17.6k +17,577 5.2%
77 QUANTUM SI INC COM CL A QSI QSI 157,363 $736.0k0.22% 0.22% AddedShares held: Q2 2021 160.0k, Q3 2021 144.4k, Q4 2021 144.4k, Q1 2022 157.4k +13.0k +12,957 9.0%
78 NEXTCURE INC COM COM 141,058 $686.0k0.21% 0.21% AddedShares held: Q2 2021 516.9k, Q3 2021 509.2k, Q4 2021 134.1k, Q1 2022 141.1k +7.0k +7,003 5.2%
79 INFLARX NV COM IFRX IFRX 349,468 $639.0k0.19% 0.19% AddedShares held: Q2 2021 666.6k, Q3 2021 631.0k, Q4 2021 331.0k, Q1 2022 349.5k +18.4k +18,420 5.6%
80 PLIANT THERAPEUTICS INC COM PLRX PLRX 90,805 $636.0k0.19% 0.19% AddedShares held: Q2 2021 108.7k, Q3 2021 86.7k, Q4 2021 86.7k, Q1 2022 90.8k +4.1k +4,093 4.7%
81 VISTAGEN THERAPEUTICS INC COM NEW VTGN VTGN 511,186 $633.0k0.19% 0.19% AddedShares held: Q2 2021 916.6k, Q3 2021 600.7k, Q4 2021 475.7k, Q1 2022 511.2k +35.5k +35,493 7.5%
82 SOLID BIOSCIENCES INC COM COM 521,155 $625.0k0.19% 0.19% UnchangedShares held: Q2 2021 675.7k, Q3 2021 521.2k, Q4 2021 521.2k, Q1 2022 521.2k
83 ASTRIA THERAPEUTICS INC COM CATB CATB 92,223 $619.0k0.19% 0.19% AddedShares held: Q2 2021 0, Q3 2021 87.6k, Q4 2021 87.6k, Q1 2022 92.2k +4.6k +4,643 5.3%
84 GEMINI THERAPEUTICS INC COM COM 443,096 $615.0k0.19% 0.19% AddedShares held: Q2 2021 426.5k, Q3 2021 421.1k, Q4 2021 421.1k, Q1 2022 443.1k +22.0k +22,046 5.2%
85 MYMD PHARMACEUTICALS INC COM COM 131,389 $612.0k0.19% 0.19% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 124.0k, Q1 2022 131.4k +7.4k +7,389 6.0%
86 TENAX THERAPEUTICS INC COM NEW COM NEW 735,097 $596.0k0.18% 0.18% AddedShares held: Q2 2021 0, Q3 2021 466.3k, Q4 2021 694.2k, Q1 2022 735.1k +40.9k +40,902 5.9%
87 RELMADA THERAPEUTICS INC COM RLMD RLMD 21,801 $588.0k0.18% 0.18% AddedShares held: Q2 2021 300.2k, Q3 2021 20.7k, Q4 2021 20.7k, Q1 2022 21.8k +1.1k +1,058 5.1%
88 KALVISTA PHARMACEUTICALS INC COM KALV KALV 39,730 $586.0k0.18% 0.18% AddedShares held: Q2 2021 97.0k, Q3 2021 96.6k, Q4 2021 36.6k, Q1 2022 39.7k +3.2k +3,154 8.6%
89 CYCLERION THERAPEUTICS INC COM COM 527,462 $585.0k0.18% 0.18% AddedShares held: Q2 2021 509.9k, Q3 2021 502.6k, Q4 2021 502.6k, Q1 2022 527.5k +24.8k +24,835 4.9%
90 HARPOON THERAPEUTICS INC COM COM 117,009 $582.0k0.18% 0.18% AddedShares held: Q2 2021 113.6k, Q3 2021 111.3k, Q4 2021 111.3k, Q1 2022 117.0k +5.7k +5,717 5.1%
91 INTERCEPT PHARMACEUTICALS IN COM ICPT ICPT 35,149 $572.0k0.17% 0.17% AddedShares held: Q2 2021 35.0k, Q3 2021 34.6k, Q4 2021 34.6k, Q1 2022 35.1k +584 +584 1.7%
92 AVALO THERAPEUTICS INC COM COM 764,271 $554.0k0.17% 0.17% AddedShares held: Q2 2021 0, Q3 2021 718.7k, Q4 2021 718.7k, Q1 2022 764.3k +45.6k +45,566 6.3%
93 DIAMEDICA THERAPEUTICS INC COM NEW DMAC DMAC 221,252 $553.0k0.17% 0.17% AddedShares held: Q2 2021 415.0k, Q3 2021 311.0k, Q4 2021 209.1k, Q1 2022 221.3k +12.2k +12,170 5.8%
94 MUSTANG BIO INC COM MBIO MBIO 546,824 $551.0k0.17% 0.17% AddedShares held: Q2 2021 526.0k, Q3 2021 506.0k, Q4 2021 506.0k, Q1 2022 546.8k +40.8k +40,791 8.1%
95 RENEO PHARMACEUTICALS INC COM COM 185,597 $546.0k0.17% 0.17% AddedShares held: Q2 2021 0, Q3 2021 175.0k, Q4 2021 175.0k, Q1 2022 185.6k +10.6k +10,597 6.1%
96 VTV THERAPEUTICS INC CL A VTVT VTVT 742,980 $536.0k0.16% 0.16% AddedShares held: Q2 2021 0, Q3 2021 0, Q4 2021 700.0k, Q1 2022 743.0k +43.0k +42,980 6.1%
97 CORBUS PHARMACEUTICALS HLDGS COM CRBP CRBP 997,627 $530.0k0.16% 0.16% AddedShares held: Q2 2021 964.1k, Q3 2021 948.5k, Q4 2021 948.5k, Q1 2022 997.6k +49.1k +49,101 5.2%
98 KODIAK SCIENCES INC COM KOD KOD 68,100 $526.0k0.16% 0.16% NewShares held: Q2 2021 0, Q3 2021 0, Q4 2021 0, Q1 2022 68.1k
99 OTONOMY INC COM OTIC OTIC 218,538 $525.0k0.16% 0.16% AddedShares held: Q2 2021 211.5k, Q3 2021 208.3k, Q4 2021 208.3k, Q1 2022 218.5k +10.2k +10,232 4.9%
100 ASSEMBLY BIOSCIENCES INC COM COM 227,076 $468.0k0.14% 0.14% AddedShares held: Q2 2021 72.5k, Q3 2021 214.9k, Q4 2021 214.9k, Q1 2022 227.1k +12.2k +12,215 5.7%

Sold out since Q4 2021

SecurityTickerShares held beforeValue then
ISHARES TR IBB IBB 24,022 $3.7m24.0k shares
IOVANCE BIOTHERAPEUTICS INC IOVA IOVA 172,521 $3.3m172.5k shares
MADRIGAL PHARMACEUTICALS INC MDGL MDGL 23,700 $2.0m23.7k shares
AMICUS THERAPEUTICS INC FOLD FOLD 164,174 $1.9m164.2k shares
ODONATE THERAPEUTICS INC 1,340,631 $1.8m1.3m shares
RAFAEL HLDGS INC RFL RFL 72,515 $370.0k72.5k shares
ARENA PHARMACEUTICALS INC ARNA ARNA 2,161 $200.0k2.2k shares
BRIDGEBIO PHARMA INC BBIO BBIO 1,500 $25.0k1.5k shares
BAUDAX BIO INC 95,059 $21.0k95.1k shares
FRAZIER LIFESCIENCES ACQU CO 941 $9.0k941 shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Call XBICall 935,600 $84.1m935.6k shares Added
NEUROCRINE BIOSCIENCES INC NBIX · Call NBIXCall 429,600 $40.3m429.6k shares New
BIOMARIN PHARMACEUTICAL INC BMRN · Call BMRNCall 313,800 $24.2m313.8k shares Added
AMGEN INC AMGN · Call AMGNCall 100,000 $24.2m100.0k shares New
BIOGEN INC BIIB · Call BIIBCall 112,200 $23.6m112.2k shares New
ALNYLAM PHARMACEUTICALS INC ALNY · Call ALNYCall 135,200 $22.1m135.2k shares Reduced
REATA PHARMACEUTICALS INC RETA · Put RETAPut 649,600 $21.3m649.6k shares Added
CELLDEX THERAPEUTICS INC NEW CLDX · Put CLDXPut 595,500 $20.3m595.5k shares Added
ALNYLAM PHARMACEUTICALS INC ALNY · Put ALNYPut 117,800 $19.2m117.8k shares New
UNITED THERAPEUTICS CORP DEL UTHR · Call UTHRCall 100,000 $17.9m100.0k shares New
HORIZON THERAPEUTICS PUB L HZNP · Call HZNPCall 158,100 $16.6m158.1k shares Reduced
CELLDEX THERAPEUTICS INC NEW CLDX · Call CLDXCall 344,100 $11.7m344.1k shares Reduced
BICYCLE THERAPEUTICS PLC BCYC · Call BCYCCall 264,700 $11.6m264.7k shares New
GILEAD SCIENCES INC GILD · Put GILDPut 181,300 $10.8m181.3k shares New
GILEAD SCIENCES INC GILD · Call GILDCall 181,300 $10.8m181.3k shares New
ATHIRA PHARMA INC Call Call 784,200 $10.6m784.2k shares Reduced
APELLIS PHARMACEUTICALS INC APLS · Call APLSCall 175,100 $8.9m175.1k shares Reduced
SAGE THERAPEUTICS INC SAGE · Call SAGECall 250,000 $8.3m250.0k shares Added
ARCUS BIOSCIENCES INC RCUS · Call RCUSCall 150,000 $4.7m150.0k shares New
BICYCLE THERAPEUTICS PLC BCYC · Put BCYCPut 106,600 $4.7m106.6k shares New
KEZAR LIFE SCIENCES INC Call Call 280,800 $4.7m280.8k shares Added
BLUEPRINT MEDICINES CORP BPMC · Call BPMCCall 64,000 $4.1m64.0k shares New
PROTAGONIST THERAPEUTICS INC PTGX · Call PTGXCall 160,700 $3.8m160.7k shares Added
AMYLYX PHARMACEUTICALS INC AMLX · Call AMLXCall 250,000 $3.2m250.0k shares New
ATHIRA PHARMA INC Put Put 200,000 $2.7m200.0k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
NEXTCURE INC NXTC · 13G · filed 2026-08-14 NXTC 10.0%≈ $804.3k no change 13G 2026-08-14
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 CNSP 9.9%≈ $704.0k +4.2 pts 13G 2026-08-14
TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 TRAW 9.5%≈ $1.3m -0.5 pts 13G 2026-08-14
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 IRLA 9.0%≈ $1.7m new 13G 2026-08-14
PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 PTHS 7.7%≈ $7.3m -0.7 pts 13G 2026-05-15
CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 7.3% new 13G 2025-02-14
CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 6.9% -1.9 pts 13G 2026-08-14
LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 LPCN 6.3% new 13G 2026-05-15